112 related articles for article (PubMed ID: 20146219)
1. Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas?
Massimino M; Cohen KJ; Finlay JL
Pediatr Blood Cancer; 2010 Apr; 54(4):641-3. PubMed ID: 20146219
[TBL] [Abstract][Full Text] [Related]
2. Use of high-dose chemotherapy in front-line therapy of childhood malignant glioma.
Massimino M; Biassoni V
Expert Rev Anticancer Ther; 2006 May; 6(5):709-17. PubMed ID: 16759162
[TBL] [Abstract][Full Text] [Related]
3. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas.
Chen B; Ahmed T; Mannancheril A; Gruber M; Benzil DL
Cancer; 2004 May; 100(10):2201-7. PubMed ID: 15139065
[TBL] [Abstract][Full Text] [Related]
5. Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors.
Marachelian A; Butturini A; Finlay J
Bone Marrow Transplant; 2008 Jan; 41(2):167-72. PubMed ID: 18176620
[TBL] [Abstract][Full Text] [Related]
6. Biological modification strategies following marrow ablative, high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell rescue (AHSCR) for pediatric brain tumors.
Zacharoulis S; Chi S; Kadota R; Kieran M
Pediatr Blood Cancer; 2010 Apr; 54(4):654-6. PubMed ID: 20146216
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.
Fine HA; Antman KH
Bone Marrow Transplant; 1992 Oct; 10(4):315-21. PubMed ID: 1330152
[TBL] [Abstract][Full Text] [Related]
8. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
[TBL] [Abstract][Full Text] [Related]
9. Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents.
Fangusaro J; Massimino M; Rutkowski S; Gururangan S
Pediatr Blood Cancer; 2010 Apr; 54(4):638-40. PubMed ID: 20146218
[TBL] [Abstract][Full Text] [Related]
10. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
Finlay JL
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
[TBL] [Abstract][Full Text] [Related]
11. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue.
Cohn SL; Moss TJ; Hoover M; Katzenstein HM; Haut PR; Morgan ER; Green AA; Kletzel M
Bone Marrow Transplant; 1997 Oct; 20(7):543-51. PubMed ID: 9337055
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
15. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness and problems of high dose chemotherapy using CBDCA, VP-16, and MCNU with peripheral blood stem cell transplantation in pediatric malignant brain tumors].
Sasajima T; Mineura K; Kowada M; Watanabe A; Takeda O
No To Shinkei; 1996 Jul; 48(7):653-8. PubMed ID: 8753001
[TBL] [Abstract][Full Text] [Related]
17. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Papadopoulos KP; Garvin JH; Fetell M; Vahdat LT; Garrett TJ; Savage DG; Balmaceda C; Bruce J; Sisti M; Isaacson S; De LaPaz R; Hawks R; Bagiella E; Antman KH; Hesdorffer CS
Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693
[TBL] [Abstract][Full Text] [Related]
18. Autologous hematopoietic stem cell transplantation for pediatric solid tumors.
Hale GA
Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
Pinkerton CR
Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
[TBL] [Abstract][Full Text] [Related]
20. Recent development in chemotherapy of paediatric brain tumours.
Grill J; Bhangoo R
Curr Opin Oncol; 2007 Nov; 19(6):612-5. PubMed ID: 17906461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
